164 related articles for article (PubMed ID: 38125787)
1. Analysis and prediction of 5-year survival in patients with cutaneous melanoma: a model-based period analysis.
Zheng S; Yu H; Zheng X; Wu UT; Ming WK; Huang H; Song J; Zhang X; Lyu J; Deng L
Front Endocrinol (Lausanne); 2023; 14():1238086. PubMed ID: 38125787
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and Prediction Analysis of 3- and 5-Year Relative Survival Rates of Patients with Cervical Cancer: A Model-Based Period Analysis.
Fan X; He W; Zhang Q; Zhang B; Dong L; Li L; Liu X
Cancer Control; 2024; 31():10732748241232324. PubMed ID: 38408865
[TBL] [Abstract][Full Text] [Related]
3. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis.
Bishop KD; Olszewski AJ
Int J Cancer; 2014 Jun; 134(12):2961-71. PubMed ID: 24272143
[TBL] [Abstract][Full Text] [Related]
5. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
6. Melanoma of the external ear: A population-based study.
Deep NL; Glasgow AE; Habermann EB; Kasperbauer JL; Carlson ML
Am J Otolaryngol; 2017; 38(3):309-315. PubMed ID: 28258767
[TBL] [Abstract][Full Text] [Related]
7. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors.
Goggins WB; Tsao H
Cancer; 2003 Feb; 97(3):639-43. PubMed ID: 12548605
[TBL] [Abstract][Full Text] [Related]
8. Trends in invasive cutaneous melanoma in Saskatchewan 1970-1999.
Ulmer MJ; Tonita JM; Hull PR
J Cutan Med Surg; 2003; 7(6):433-42. PubMed ID: 15926213
[TBL] [Abstract][Full Text] [Related]
9. Analysis and prediction of relative survival trends in patients with non-Hodgkin lymphoma in the United States using a model-based period analysis method.
Xie S; Yu Z; Feng A; Zheng S; Li Y; Zeng Y; Lyu J
Front Oncol; 2022; 12():942122. PubMed ID: 36237337
[TBL] [Abstract][Full Text] [Related]
10. Incidence of childhood and adolescent melanoma in the United States: 1973-2009.
Wong JR; Harris JK; Rodriguez-Galindo C; Johnson KJ
Pediatrics; 2013 May; 131(5):846-54. PubMed ID: 23589817
[TBL] [Abstract][Full Text] [Related]
11. Malignant Melanoma in African-Americans: A Population-Based Clinical Outcomes Study Involving 1106 African-American Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1988-2011).
Mahendraraj K; Sidhu K; Lau CSM; McRoy GJ; Chamberlain RS; Smith FO
Medicine (Baltimore); 2017 Apr; 96(15):e6258. PubMed ID: 28403068
[TBL] [Abstract][Full Text] [Related]
12. Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort.
Sanchez A; Rodríguez D; Allard CB; Bechis SK; Sullivan RJ; Boeke CE; Kuppermann D; Cheng JS; Barrisford GW; Preston MA; Feldman AS
Urol Oncol; 2016 Apr; 34(4):166.e7-14. PubMed ID: 26739672
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous angiosarcoma. Analysis of 434 cases from the Surveillance, Epidemiology, and End Results Program, 1973-2007.
Albores-Saavedra J; Schwartz AM; Henson DE; Kostun L; Hart A; Angeles-Albores D; Chablé-Montero F
Ann Diagn Pathol; 2011 Apr; 15(2):93-7. PubMed ID: 21190880
[TBL] [Abstract][Full Text] [Related]
14. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
15. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
17. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.
Bradford PT; Goldstein AM; McMaster ML; Tucker MA
Arch Dermatol; 2009 Apr; 145(4):427-34. PubMed ID: 19380664
[TBL] [Abstract][Full Text] [Related]
18. Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.
Enninga EAL; Moser JC; Weaver AL; Markovic SN; Brewer JD; Leontovich AA; Hieken TJ; Shuster L; Kottschade LA; Olariu A; Mansfield AS; Dronca RS
Cancer Med; 2017 Oct; 6(10):2203-2212. PubMed ID: 28879661
[TBL] [Abstract][Full Text] [Related]
19. Reporting cutaneous melanoma to cancer registries in the United States.
Hall HI; Jamison P; Fulton JP; Clutter G; Roffers S; Parrish P
J Am Acad Dermatol; 2003 Oct; 49(4):624-30. PubMed ID: 14512907
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036.
Garbe C; Keim U; Gandini S; Amaral T; Katalinic A; Hollezcek B; Martus P; Flatz L; Leiter U; Whiteman D
Eur J Cancer; 2021 Jul; 152():18-25. PubMed ID: 34062483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
